BRIEF

on PL BioScience GmbH

PL BioScience Announces Participation in Upcoming Conferences

PL BioScience GmbH, a company based in Aachen, Germany, has revealed its attendance at six major life sciences conferences this autumn. Specializing in Human Platelet Lysate (HPL) for cell expansion, the firm will showcase its products and network with industry peers.

The events include the Festival of Biologics in Basel, BioJapan in Yokohama, and Innovative Therapies Days 2025 in Besançon. Notably, PL BioScience will also attend CPHI Frankfurt 2025, BIO-EUROPE 2025 in Vienna, and Cell 2025 in London. Each event provides opportunities for meeting with the company's management and sales teams.

These events mark significant opportunities for PL BioScience to engage with various stakeholders in the life sciences industry, offering insights into their HPL innovations.

R. E.

Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all PL BioScience GmbH news